These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 30995454)
21. Amylin induces hypoglycemia in mice. Guerreiro LH; Da Silva D; Sola-Penna M; Mizurini DM; Lima LM An Acad Bras Cienc; 2013 Mar; 85(1):349-54. PubMed ID: 23460444 [TBL] [Abstract][Full Text] [Related]
22. Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM. Kolterman OG; Schwartz S; Corder C; Levy B; Klaff L; Peterson J; Gottlieb A Diabetologia; 1996 Apr; 39(4):492-9. PubMed ID: 8778001 [TBL] [Abstract][Full Text] [Related]
23. Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone. Edelman SV; Weyer C Diabetes Technol Ther; 2002; 4(2):175-89. PubMed ID: 12079621 [TBL] [Abstract][Full Text] [Related]
24. Involvement of cyclooxygenase 2 and prostagladin E(2) in the effects of insulin on gastric emptying in male rats. Huang W-; Hung C-; Chen M-; Wang J-; Doong M-; Wang C-; Hung C-; Wang PS J Physiol Pharmacol; 2009 Sep; 60(3):109-18. PubMed ID: 19826189 [TBL] [Abstract][Full Text] [Related]
25. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus. Baron AD; Kim D; Weyer C Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):63-82. PubMed ID: 12477297 [TBL] [Abstract][Full Text] [Related]
26. Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus. Nyholm B; Brock B; Ørskov L; Schmitz O Expert Opin Investig Drugs; 2001 Sep; 10(9):1641-52. PubMed ID: 11772274 [TBL] [Abstract][Full Text] [Related]
27. Amylin effect in extrapancreatic tissues participating in glucose homeostasis, in normal, insulin-resistant and type 2 diabetic state. Moreno P; Acitores A; Gutiérrez-Rojas I; Nuche-Berenguer B; El Assar M; Rodriguez-Mañas L; Gomis R; Valverde I; Visa M; Malaisse WJ; Novials A; González N; Villanueva-Peñacarrillo ML Peptides; 2011 Oct; 32(10):2077-85. PubMed ID: 21939703 [TBL] [Abstract][Full Text] [Related]
28. Pramlintide: A new tool in diabetes management. Want LL; Ratner RE Curr Diab Rep; 2006 Nov; 6(5):344-9. PubMed ID: 17076994 [TBL] [Abstract][Full Text] [Related]
30. Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats. Young AA; Cooper GJ; Carlo P; Rink TJ; Wang MW Am J Physiol; 1993 Jun; 264(6 Pt 1):E943-50. PubMed ID: 8333519 [TBL] [Abstract][Full Text] [Related]
31. Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide. Mack CM; Smith PA; Athanacio JR; Xu K; Wilson JK; Reynolds JM; Jodka CM; Lu MG; Parkes DG Diabetes Obes Metab; 2011 Dec; 13(12):1105-13. PubMed ID: 21733060 [TBL] [Abstract][Full Text] [Related]
34. [Role of amylin in glucose homeostasis and its perspective use in diabetes management]. Otto-Buczkowska E; Mazur-Dworzecka U; Dworzecki T Przegl Lek; 2008; 65(3):135-9. PubMed ID: 18624122 [TBL] [Abstract][Full Text] [Related]
35. Comparative Benefits and Harms of Basal Insulin Analogues for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Madenidou AV; Paschos P; Karagiannis T; Katsoula A; Athanasiadou E; Kitsios K; Bekiari E; Matthews DR; Tsapas A Ann Intern Med; 2018 Aug; 169(3):165-174. PubMed ID: 29987326 [TBL] [Abstract][Full Text] [Related]
37. Development of Cagrilintide, a Long-Acting Amylin Analogue. Kruse T; Hansen JL; Dahl K; Schäffer L; Sensfuss U; Poulsen C; Schlein M; Hansen AMK; Jeppesen CB; Dornonville de la Cour C; Clausen TR; Johansson E; Fulle S; Skyggebjerg RB; Raun K J Med Chem; 2021 Aug; 64(15):11183-11194. PubMed ID: 34288673 [TBL] [Abstract][Full Text] [Related]
38. The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes. Rodriguez LM; Mason KJ; Haymond MW; Heptulla RA Pediatr Res; 2007 Dec; 62(6):746-9. PubMed ID: 17957149 [TBL] [Abstract][Full Text] [Related]
39. Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations. Luippold G; Bedenik J; Voigt A; Grempler R PLoS One; 2016; 11(6):e0156346. PubMed ID: 27253523 [TBL] [Abstract][Full Text] [Related]
40. Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study. Weyer C; Gottlieb A; Kim DD; Lutz K; Schwartz S; Gutierrez M; Wang Y; Ruggles JA; Kolterman OG; Maggs DG Diabetes Care; 2003 Nov; 26(11):3074-9. PubMed ID: 14578242 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]